MGAT4EP and breast cancer: Further multivariate Cox regression analysis confirmed that MGAT4EP expression remained a significant factor for poor prognosis in breast cancer patients, with an HR of 2.661 (95% CI: 1.076–6.579), p = .034 (Supplementary Figure S2b).